Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD

被引:0
|
作者
Thornton, Julia [1 ]
Luna, Yesenia [1 ]
Wong, Ken [2 ]
Zhang, Jie [2 ]
Chen, Susan [1 ]
Goldman, Dana [3 ,4 ]
机构
[1] Precis Hlth Econ, Res, Los Angeles, CA 90025 USA
[2] Novartis Pharmaceut, Hlth Econ & Outcomes Res, E Hanover, NJ 07936 USA
[3] Univ Southern Calif, Sch Policy Planning & Dev, Los Angeles, CA 90089 USA
[4] Univ Southern Calif, Sch Pharm, Los Angeles, CA 90089 USA
关键词
COPD; -; management; Pneumonia; Treatments;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
1526
引用
收藏
页数:1
相关论文
共 50 条
  • [32] Inhaled Corticosteroids in Asthma and the Risk of Pneumonia
    Kim, Min-Hye
    Rhee, Chin Kook
    Shim, Ji-Su
    Park, So Young
    Yoo, Kwang Ha
    Kim, Bo Yeon
    Bae, Hye Won
    Sim, Yun Su
    Chang, Jung Hyun
    Cho, Young-Joo
    Lee, Jin Hwa
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (06) : 795 - 805
  • [33] Inhaled corticosteroids and pneumonia in COPD: An association looking for evidence
    Turner, Mark O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (05) : 555 - 556
  • [34] Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD
    Price, David
    Yawn, Barbara
    Brusselle, Guy
    Rossi, Andrea
    PRIMARY CARE RESPIRATORY JOURNAL, 2013, 22 (01): : 92 - 100
  • [35] Risk of Fracture and Osteoporosis in Patients With COPD and Inhaled Corticosteroids Treatment
    Zhang, Nini
    Fan, Xinhui
    Zhang, Yuyu
    Xu, Ning
    Li, Li
    RESPIRATORY CARE, 2023, 68 (12) : 1719 - 1727
  • [36] RISK FACTORS FOR THE DEVELOPMENT OF PNEUMONIA IN PATIENTS TREATED WITH INHALED CORTICOSTEROIDS
    Hirano, R.
    Ishii, H.
    Igata, F.
    Matsumoto, T.
    Fujita, M.
    Watanabe, K.
    RESPIROLOGY, 2014, 19 : 109 - 109
  • [37] Inhaled corticosteroids are associated with increased pneumonia risk in asthma patients
    Cho, Y.
    Kim, M.
    Rhee, C. K.
    Yoo, K. H.
    Kim, B. Y.
    Bae, H. W.
    Shim, Y. S.
    Chang, J. H.
    Lee, J. H.
    ALLERGY, 2019, 74 : 722 - 722
  • [38] DIAGNOSTIC CRITERIA FOR PNEUMONIA AND OBSERVED RISK OF PNEUMONIA IN STUDIES OF INHALED CORTICOSTEROIDS FOR COPD: A META-ANALYSIS
    Kobylianskii, Jane
    Kraus, Nicole
    Stanbrook, Matthew
    CHEST, 2020, 158 (04) : 1787A - 1787A
  • [39] THE RISK OF PNEUMONIA IN COPD PATIENTS WITH CONCOMITANT BRONCHIECTASIS USING INHALED CORTICOSTEROIDS: A UK CASE-CONTROL STUDY
    Ritchie, A. I.
    Singanayagam, A.
    Mitchell, S.
    Wedzicha, J.
    Shah, A.
    Bloom, C.
    THORAX, 2022, 77 : A70 - A70